Investigator
Abhik Das
RESEARCH TRIANGLE INSTITUTE · funded by NICHD, NHLBI
- Companies
- 8
- Grants
- 9
- Non-dilutive funding
- $14M
- First award
- Apr 1, 2018
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Mar 1, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
Grant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
Grant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
Grant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
ImmunologyGrant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
Grant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
Grant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
Grant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
Grant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U24
Neonatal Research Network Data Coordinating Center (DCC) 2023-2028
$822kMar 1, 2026NICHDRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11466555 (opens the source filing in a new tab)
- U24
Neonatal Research Network Data Coordinating Center (DCC) 2023-2028
$722kSep 1, 2025NICHDRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11402434 (opens the source filing in a new tab)
- U01
Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial)
$806kAug 6, 2025NICHDRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11223010 (opens the source filing in a new tab)
- U24
2/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) - DCC Resubmission
$1.2MJul 1, 2024NHLBIRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11124709 (opens the source filing in a new tab)
- U24
2/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) - DCC Resubmission
$1.2MJul 1, 2024NHLBIRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11385461 (opens the source filing in a new tab)
- U24
2/2 Neonatal Platelet Transfusion Threshold Trial (NeoPlaTT)
$1.5MMay 15, 2024NHLBIRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11088186 (opens the source filing in a new tab)
- U24
2/2 Neonatal Platelet Transfusion Threshold Trial (NeoPlaTT)
$1.4MMay 15, 2024NHLBIRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11322622 (opens the source filing in a new tab)
- U24
Neonatal Research Network Data Coordinating Center (DCC) 2023-2028
$3.1MApr 1, 2018NICHDRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11074073 (opens the source filing in a new tab)
- U24
Neonatal Research Network Data Coordinating Center (DCC) 2023-2028
$3.1MApr 1, 2018NICHDRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11310029 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources